Insights

OralogiK Advantage Procure opportunities around OralogiK powered products as BDD expands towards the clinic, offering a potential for collaboration on delayed-release formulations and phase-appropriate clinical development services.

Clinical Integration Leverage BDD’s full clinical package—from protocol development to regulatory submission—to offer end-to-end outsourced services for pharma clients seeking accelerated development timelines and tight GCP-compliant study reporting.

Gamma Analytics Capitalize on BDD’s gamma scintigraphy and pharmacokinetic capabilities to position joint offerings for in vivo formulation evaluation, particularly for oral delivery systems requiring site-specific release data.

Collaborative Growth Target partnerships with biotech firms and nutraceuticals seeking modified or controlled release technologies, using BDD’s flexible, customer-centric approach to tailor dosing forms and lifecycle management.

Financial Backing Recognize readiness for larger deal flows given revenue scale and ongoing funding; propose strategic alliances or sponsored programs that align with BDD’s pipeline expansion and clinical advancement objectives.

Similar companies to BDD

BDD Tech Stack

BDD uses 8 technology products and services including Microsoft Clarity, Wix, WordPress, and more. Explore BDD's tech stack below.

Media & News

BDD's Email Address Formats

BDD uses at least 2 email formats:
BDD Email FormatsExamplePercentage
First.Last@bddpharma.comJohn.Doe@bddpharma.com
97%
FirstLas@bddpharma.comJohnDoe@bddpharma.com
3%

Frequently Asked Questions

What is BDD's stock symbol?

Minus sign iconPlus sign icon
BDD is a publicly traded company; the company's stock symbol is BBDD.L.

What is BDD's official website and social media links?

Minus sign iconPlus sign icon
BDD's official website is bddpharma.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does BDD generate?

Minus sign iconPlus sign icon
As of October 2026, BDD's annual revenue is estimated to be $10M - $25M.

What is BDD's NAICS code?

Minus sign iconPlus sign icon
BDD's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does BDD have currently?

Minus sign iconPlus sign icon
As of October 2026, BDD has approximately 53 employees across 3 continents, including Europe, North America and Asia. Key team members include Ceo: C. T., Cfo: J. K. and Cro Manager: A. M. Explore BDD's employee directory with LeadIQ.

What industry does BDD belong to?

Minus sign iconPlus sign icon
BDD operates in the Pharmaceutical Manufacturing industry.

What technology does BDD use?

Minus sign iconPlus sign icon
BDD's tech stack includes Microsoft Clarity, Wix, WordPress, Osano, Shopify, Google Cloud, Office 365 and Magnific Popup.

What is BDD's email format?

Minus sign iconPlus sign icon
BDD's email format typically follows the pattern of First.Last@bddpharma.com. Find more BDD email formats with LeadIQ.

How much funding has BDD raised to date?

Minus sign iconPlus sign icon
As of October 2026, BDD has raised $7M in funding. The last funding round occurred on Sep 16, 2023 for $2.5M.

When was BDD founded?

Minus sign iconPlus sign icon
BDD was founded in 1999.
BDD logo

BDD

Pharmaceutical ManufacturingScotland, United Kingdom51-200 Employees

BDD is a pharmaceutical manufacturing company that integrates drug delivery expertise with clinical capabilities to accelerate product development and support life cycle management. Its offerings include rapid parallel clinical testing through its SWIFT platform, as well as specialized formulations that provide controlled release at targeted sites, enabling potentially improved therapeutic outcomes. The firm also operates a clinical division that handles protocol development, study documentation, regulatory submissions, and production of regulatory-compliant study reports, alongside gamma scintigraphy to study the in vivo behavior of formulations and related pharmacokinetic data. Based in Glasgow, Scotland, BDD works with life sciences customers to address needs in modified and delayed-release oral formulations, aiming to shorten development timelines and generate value-added products. The company appears to serve developers of new therapies and established partners seeking to optimize oral drug delivery and clinical data generation, with recent activity including a product advancement toward the clinic using its OralogiK technology.

Section iconCompany Overview

Stock Symbol
BBDD.L
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1999
Employees
51-200

Section iconFunding & Financials

  • $7M

    BDD has raised a total of $7M of funding over 3 rounds. Their latest funding round was raised on Sep 16, 2023 in the amount of $2.5M as a Venture Round.

  • $10M - $25M

    BDD's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.